Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction

NCT05135377 is registered in ClinicalTrials.gov with Waleed Alqurashi as lead sponsor.

NCT NCT05135377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction
Lead sponsor
Waleed Alqurashi
Phase
Observational
Overall status
Active, not recruiting
Start date
April 11, 2022
Completion date
December 31, 2025
Enrollment
1,682 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

anaphylaxis